Over Counter Drugs

Real-Time Monitoring of Over-the-Counter Drug Policies

Document Statistics

Documents by Year

Documents by Type

Understanding Over-the-Counter Drug Regulations

Over-the-counter (OTC) drugs are medications available without a prescription, providing easy access to treatment for minor health issues. The regulation of these drugs is crucial, as it ensures safety, efficacy, and proper labeling for consumer use. Monitoring these regulations is essential for various stakeholders who need to stay informed about policy changes and regulatory updates.

Why Monitoring Matters for Stakeholders

  1. Pharmaceutical Companies: These companies develop and market OTC drugs, thus must stay ahead of regulatory updates to ensure compliance and seize any emerging opportunities for new product lines.
  2. Healthcare Providers: Physicians and pharmacists need to stay informed about OTC drug changes to safely advise patients on self-medication options.
  3. Regulatory Affairs Professionals: These individuals work to ensure their organizations comply with FDA guidelines, making real-time information on rule changes crucial for maintaining compliance.
  4. Legal Experts: Lawyers specializing in healthcare and pharmaceutical law need to understand regulatory shifts to provide accurate advice and advocacy.

Recent Trends and Regulatory Impacts

The push for transparency and safety in OTC drug packaging and labeling has been a significant trend in recent years. The FDA has been actively involved in implementing stricter labeling requirements to ensure consumers understand proper dosages and potential risks.

The increase in self-medication, combined with the growth of online retailing for OTC drugs, has led the FDA to focus on cybersecurity measures to protect consumers. This trend highlights the importance of having a robust monitoring system to keep track of policy changes.

Benefits of Real-Time Monitoring

Using an AI-powered monitoring system like FedMonitor.com ensures stakeholders receive updates on critical federal documentation that impacts their operations directly. This includes:

  • Seizing Funding Opportunities: Stay informed about federal grants and initiatives related to OTC drug development.
  • Staying Ahead of Policy Changes: Anticipate changes in legislation that could affect product legality or marketability.
  • Simplifying Monitoring Efforts: Reduce the time spent manually searching for regulatory updates by using automated tracking tools.
  • Mitigating Risks from Rule Changes: Quickly adapt to new rules, reducing compliance risks.

Seamless Integration and Alerts

FedMonitor supports various integrations allowing updates to be sent directly to platforms your team already uses, such as Slack, Microsoft Teams, and Salesforce, in addition to traditional email or SMS notifications. This ensures that the right people receive the right information exactly when they need it most.

Staying informed has never been easier. To learn more about how FedMonitor can enhance your regulatory monitoring, visit our FAQ or contact us for further assistance. Empower your team with timely, relevant updates and keep abreast of essential regulatory changes effortlessly.

Topic Details

Related Agencies

Related Searches

Latest Documents

Title Type Published
Health and Human Services Department > FDA, CMS, ACF
Regulatory Clean Up Initiative
The U.S Department of Health and Human Services (HHS) is amending its regulations to make miscellaneous corrections, including correcting references to other regulations, misspellings and other typographical errors. This document is necessary to info...
 Rule Nov 16, 2020
Health and Human Services Department > FDA
Sunscreen Drug Products for Over-the-Counter Human Use
The Food and Drug Administration (FDA or Agency) is issuing this proposed rule to put into effect a final monograph for nonprescription, over-the-counter (OTC) sunscreen drug products. This proposed rule describes the conditions under which FDA propo...
 Proposed Rule Feb 26, 2019
Health and Human Services Department > FDA
Food and Drug Administration Review and Action on Over-the-Counter Time and Extent Applications
The Food and Drug Administration (FDA or Agency) is amending its nonprescription (over-the-counter or OTC) drug regulations. This final rule supplements the time and extent application (TEA) process for OTC drugs by establishing timelines and perform...
 Rule Nov 23, 2016
Health and Human Services Department > FDA
Food and Drug Administration Review and Action on Over-the-Counter Time and Extent Applications
The Food and Drug Administration (FDA or Agency) is proposing to amend its nonprescription (over-the-counter or OTC) drug regulations. The proposed rule, if finalized as proposed, would supplement the time and extent application (TEA) process for OTC...
 Proposed Rule Apr 04, 2016
Health and Human Services Department > FDA
Fixed-Combination and Co-Packaged Drugs: Applications for Approval and Combinations of Active Ingredients Under Consideration for Inclusion in an Over-the-Counter Monograph
The Food and Drug Administration (FDA or the Agency) is proposing to revise its regulations on prescription fixed-combination drugs to apply the regulations to both prescription and nonprescription fixed-combination and co-packaged drugs and combinat...
 Proposed Rule Dec 23, 2015
Health and Human Services Department > FDA
Division of Freedom of Information; Change of Office Name, and Removal of Address, Telephone Number, and Fax Number; Technical Amendment
The Food and Drug Administration (FDA) is amending the Agency's regulations to change the Division of Freedom of Information's (FOI's) name, and remove the address, telephone number, fax number, and Public Reading Room fax number and room number and...
 Rule Nov 14, 2014
Health and Human Services Department > FDA
Postmarketing Safety Reports for Human Drug and Biological Products; Electronic Submission Requirements
The Food and Drug Administration (FDA or we) is amending its postmarketing safety reporting regulations for human drug and biological products to require that persons subject to mandatory reporting requirements submit safety reports in an electronic...
 Rule Jun 10, 2014
Health and Human Services Department > FDA
Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Reopening of Administrative Record
The Food and Drug Administration (FDA) is issuing this proposed rule to amend the 1994 tentative final monograph or proposed rule (the 1994 TFM) for over-the-counter (OTC) antiseptic drug products. In this proposed rule, we are proposing to establish...
 Proposed Rule Dec 17, 2013
Health and Human Services Department > FDA
Labeling for Bronchodilators To Treat Asthma; Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use
The Food and Drug Administration (FDA) is amending the final monograph (FM) for over-the-counter (OTC) bronchodilator drug products to add additional warnings (e.g., an "Asthma alert") and to revise the indications, warnings, and directions in the la...
 Rule Jul 26, 2011
Health and Human Services Department > FDA
Division of Freedom of Information; Change of Office Name, Address, Telephone Number, and Fax Number; Technical Amendments
The Food and Drug Administration (FDA) is amending the Agency's regulations to reflect changes to the Division of Freedom of Information's office name, address, telephone number, and fax number and the Division of Freedom of Information Public Readin...
 Rule Jun 01, 2011
Health and Human Services Department > FDA
Professional Labeling for Laxative Drug Products for Over-the-Counter Human Use; Proposed Amendment to the Tentative Final Monograph
The Food and Drug Administration (FDA) is issuing a proposed rulemaking to amend the tentative final monograph (1985 TFM) for over- the-counter (OTC) laxative drug products (products that relieve occasional constipation). FDA is proposing that sodium...
 Proposed Rule Feb 11, 2011
Health and Human Services Department > FDA
Classification of Benzoyl Peroxide as Safe and Effective and Revision of Labeling to Drug Facts Format; Topical Acne Drug Products for Over-The-Counter Human Use; Final Rule
We, the Food and Drug Administration (FDA), are issuing this final rule to include benzoyl peroxide as a generally recognized as safe and effective (GRASE) active ingredient in over-the-counter (OTC) topical acne drug products. In addition, this fina...
 Rule Mar 04, 2010
Health and Human Services Department > FDA
Astringent Drug Products That Produce Aluminum Acetate; Skin Protectant Drug Products for Over-the-Counter Human Use; Technical Amendment
We (Food and Drug Administration (FDA)) are amending the final monograph (FM) for over-the-counter (OTC) skin protectant astringent drug products. This amendment clarifies that aluminum acetate solutions, produced by dissolving aluminum sulfate tetra...
 Rule Mar 06, 2009
Health and Human Services Department > FDA
Skin Protectant Drug Products for Over-the-Counter Human Use; Reduced Labeling; Technical Amendment
The Food and Drug Administration (FDA) is amending the regulation that establishes conditions under which over-the-counter (OTC) skin protectant drug products are generally recognized as safe and effective (GRASE) and not misbranded. This amendment r...
 Rule Feb 01, 2008
Health and Human Services Department > FDA
Sunscreen Drug Products for Over-the-Counter Human Use; Proposed Amendment of Final Monograph
The Food and Drug Administration (FDA) is issuing a proposed rule that would amend the final monograph (FM) for over-the-counter (OTC) sunscreen drug products as part of FDA's ongoing review of OTC drug products. This amendment addresses formulation,...
 Proposed Rule Aug 27, 2007
Health and Human Services Department > FDA
Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use; Proposed Amendment of the Tentative Final Monograph; Required Warnings and Other Labeling
The Food and Drug Administration (FDA) is proposing to amend its over-the-counter (OTC) labeling regulations and the tentative final monograph (TFM) for OTC internal analgesic, antipyretic, and antirheumatic (IAAA) drug products to include new warnin...
 Proposed Rule Dec 26, 2006
Health and Human Services Department > FDA
External Analgesic Drug Products for Over-the-Counter Human Use; Reopening of the Administrative Record and Amendment of Tentative Final Monograph
The Food and Drug Administration (FDA) is reopening the administrative record for the rulemaking for over-the-counter (OTC) external analgesic drug products to accept comments and data concerning OTC external analgesic drug products that have been fi...
 Proposed Rule Jul 17, 2003
Health and Human Services Department > FDA
Topical Antifungal Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical antifungal drug products. The amendment makes a minor change in the indications for these drug products. This final rule is part...
 Rule Aug 29, 2000
Health and Human Services Department > FDA
Topical Otic Drug Products for Over-the-Counter Human Use; Products for Drying Water-Clogged Ears; Amendment of Monograph; Lift of Partial Stay of Effective Date
The Food and Drug Administration (FDA) is issuing a final rule amending the monograph for over-the-counter (OTC) topical otic drug products (the regulation that establishes conditions under which these drug products are generally recognized as safe a...
 Rule Aug 10, 2000
Health and Human Services Department > FDA
Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Over-the-Counter Human Use; Amendment of Final Monograph for OTC Antitussive Drug Products
The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph for over-the-counter (OTC) antitussive drug products (products that relieve cough). Use of topical/inhalant products containing camphor or menthol near a flam...
 Rule Aug 01, 2000

Related Topics

O

Over-the-counter drugs

L

Labeling

D

Drugs

R

Reporting & Recordkeeping Requirements

A

Administrative Practice & Procedure

M

Medical Devices